RESEARCH VIA EQUITY REPORT 28/05/2013
DAILY MARKET ANALYSIS
WWW.RESEARCHVIA.COM
+91-99777-85000
ECONOMY ANALYSIS Nifty ends 100 pts up; RIL, Sun Pharma up 5% Economists forecast India Q4 GDP at 4.8% TTK Healthcare Q4 net declines 39.6% to Rs 2.24cr 3G case: HC issues contempt notices to Idea Cellular, others JSW Steel's Q4 net down 24% on higher interest cost Reliance Communications up 4% on pre-paid call rates hike
MARKET ANALYSIS The BSE benchmark Sensex today surged the most in two weeks by jumping 326 points to close at 20,030.77 points on all-round buying led by a rally in RILBSE 5.12 % and Sun PharmaBSE 4.66 % on positive reports amid a firming global trend. The Sensex shot up by 326.44 points, or 1.66 per cent, to 20,030.77, led by consumer durables, and oil and gas sectors driven by a steep rise in Reliance Industries. The broad-based National Stock Exchange index Nifty shot up by 99.60 points, or 1.66 per cent, to 6,083.15. MCX-SX flagship index SX40 also closed higher by 214.5 points, or 1.84 per cent, at 11,681.13. Sun Pharma spurted by 4.66 per cent to Rs 1,014.85 ahead of the quarter earnings, while Bharti Airtel BSE 3.31 % rose by 3.31 per cent to Rs 209.15 The major gainers were Infosys, Coal India, BHEL BSE 2.02 %, Dr Reddy's Lab, HDFC Bank, Hindalco, Hero MotoCorpBSE 1.62 %, Jindal Steel, Tata MotorsBSE 2.20 %, Tata SteelBSE 1.23 %, TCS and Wipro.
WWW.RESEARCHVIA.COM
+91- 99777-85000
MAJOR INDICES INDIAN MARKETS INDEX
CLOSE
CHANGE
% CHANGE
SENSEX
20030.77
326.44
1.66
NIFTY
6083.15
99.60
1.66
BANK NIFTY
12961.55
192.20
1.51
ASIAN MARKETS
EUROPEAN MARKET
INDEX
CLOSE
CHANGE
INDEX
CLOSE
CHANGE
NIKKEI
14142.65
-469.80
FTSE
6654.34
-42.45
STRAITS TIMES
3391.30
-1.87
CAC
3982.87
26.08
HANG SENG
22686.05
67.38
DAX
8349.75
44.43
TAIWAN INDEX
8280.10
70.32
KOSPI
1979.97
6.52
US MARKETS
WWW.RESEARCHVIA.COM
INDEX
CLOSE
CHANGE
DOW FUTURES
15309.00
2.00
NASDAQ FUTURES
2994.00
1.75
+91- 99777-85000
DAILY GAINERS AND LOOSERS
GAINERS SCRIPS
RATE
VOL. (000)
PR. CLOSE
NET
% CHANGE
CHANGE
Indusind
529.35
2357.82
498.25
31.1
6.24
RIL
828.3
4332.76
786.45
41.85
5.32
Sun Pharma
1013.7
1674.8
968.85
44.85
4.63
Jindal Steel
306.6
2559.86
295.05
11.55
3.91
Ranbaxy
404.8
1400.44
389.7
15.1
3.87
LOOSERS SCRIPS
RATE
VOL. (000)
PR. CLOSE
NET
% CHANGE
CHANGE
Cipla
401.5
838.32
408.5
-7
-1.71
M&M
951.9
622.16
968.1
-16.2
-1.67
Maruti
1648.75
584.14
1674.9
-26.15
-1.56
Lupin
759.15
1352.95
769.65
-10.5
-1.36
BOB
682.25
1527.84
691.5
-9.25
-1.34
WWW.RESEARCHVIA.COM
+91- 99777-85000
FII AND DII TRADING DATA CATEGORY
DATE
BUY VALUE
SELL VALUE
NET VALUE
FII
27-May-2013
2525.75
2119.72
406.03
DII
27-May-2013
696.51
1212.9
-516.39
DAILY PIVOTS INDEX
S1
S2
PP
R1
R2
NIFTY
5993
5918
6046
6121
6174
BANK NIFTY
12723
12558
12843
13008
13128
Upcoming quarterly results Aban Offshore Bombay Dyeing Colgate GAIL Godrej Ind Gravita India Havells India Hindalco HPCL PVR Tata Comm Tata Global Bev WWW.RESEARCHVIA.COM
28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013 28-May-2013
Scrips in Ban period HDIL RENUKA
+91- 99777-85000
DISCLAIMER All data and reports at Research Via are only information services for subscribers and are not individualized recommendations to buy or sell securities, nor offers to buy or sell securities. Under any All data and reports at Research only information services for subscribers and are not circumstances the subscription amountVia paid are to Research Via are not refundable. Investment in equity shares, futures, options and commodities Sincere efforts have been to present individualized recommendations to has buyitsorown sellrisks. securities, nor offers to made buy or sell securities. the right investment perspective. The information contained herein is based on analysis and on sources Under any circumstances the subscription amount paid to Research Via are not refundable. that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This Investment inpersonal equity shares, futures, and commodities has its own material is for information and weoptions are not responsible for any loss incurred duerisks. to it &Sincere take no efforts responsibility whatsoever for any profits or lossperspective. which may arise from the recommendations have been made to present thefinancial right investment The information contained herein above.
is based on analysis and on sources that we consider reliable. We, however, do not vouch for the
This Website is forcompleteness information purposes only. Thematerial information on this should not beand we are not accuracy or the thereof. This is contained for personal information construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for the units of the responsible for any loss incurred due to it & take no responsibility whatsoever for any financial schemes of Research Via. Research Via is neither responsible nor liable for third party content provided
profits or loss mayaspect ariseoffrom the recommendations above. or content fromwhich any other any other Website, which may be accessed from this Website. A
possibility exists that the site could include inaccuracies or errors. Additionally, a possibility exist that
This Website additions, is for information information contained on this should not be unauthorized deletions orpurposes alterationsonly. could The be made by third parties to the site. Although construed Research Via as attempts an offertotoensure sell, athe solicitation integrity, correctness of an offer andtoauthenticity buy, or a of recommendation the site, it makes no for the units whatsoever as to its completeness, correctness or accuracy. In the event, suchfor an third party ofguarantees the schemes of Research Via. Research Via is neither responsible northat liable inaccuracy arises, please inform Research Via so that it can be corrected.
content provided or content from any other aspect of any other Website, which may be accessed Research and its owners/affiliates not liable damages any performance, failureor of errors. from thisVia Website. A possibilityareexists thatforthe site caused could byinclude inaccuracies performance, error, omission, interruption, deletion, defect, delay in transmission or operations,
Additionally, possibility exist unauthorized additions, oraccounts. alterations could be computer virus,a communications linethat failure, and unauthorized access todeletions the personal made by Via third parties to the Although Research Viaofattempts to or ensure integrity, Research is not responsible forsite. any technical failure or malfunction the software delays the of any kind. We are also responsible forofnon-receipt or e-mails. Research Via is not correctness andnot authenticity the site,of registration it makes details no guarantees whatsoever as to its responsible for the content of any of the linked sites. By providing access to other web-sites, Research
completeness, correctness or accuracy. In the event, that such an inaccuracy arises, please Via is neither recommending nor endorsing the content available in the linked websites. inform Research Via so that it can be corrected. Research Via and its owners/affiliates are not liable for damages caused by any performance, failure of performance, error, omission, interruption, deletion, defect, delay in transmission or operations, computer virus, communications line failure, and unauthorized access to the personal accounts. Research Via is not responsible for any technical failure or malfunction of the software or delays of any kind. We are also not responsible for non-receipt of registration details or e-mails. Research Via is not responsible for the content of any of the linked sites. By providing access to other web-sites, Research Via is neither recommending nor endorsing the content available in the linked websites. WWW.RESEARCHVIA.COM
+91- 99777-85000